Check out our featured webcasts from Pharmaceutical Technology®! #Formulation #PharmaceuticalDevelopment #APIs
Pharmaceutical Technology
Book and Periodical Publishing
Iselin, NJ 5,048 followers
Bringing you the latest in global pharmaceutical development and manufacturing industry.
About us
Pharmaceutical Technology is the authoritative source of peer-reviewed research and expert analyses for scientists, engineers, and managers engaged in process development, manufacturing, formulation and drug delivery, API synthesis, analytical technology and testing, packaging, IT, outsourcing, and regulatory compliance in the pharmaceutical and biotechnology industries.
- Website
-
http://www.pharmtech.com
External link for Pharmaceutical Technology
- Industry
- Book and Periodical Publishing
- Company size
- 501-1,000 employees
- Headquarters
- Iselin, NJ
- Type
- Privately Held
Locations
-
Primary
485F US Hwy 1 South, Ste. 210
Iselin, NJ 08830-3009, US
Employees at Pharmaceutical Technology
Updates
-
Get Behind the headlines to understand what trends and personalities are driving future pharma industry behavior -
Behind the headlines: Episode 4 We discussed some the biggest stories of the week, including: - Pfizer withdrawal of Oxbryta for sickle cell diseasse - Alongside that, Vertex Pharmaceuticals tips sickle cell casgevy manufacturing to Lonza - Emergent BioSolutions MPOXX vaccine $400M contract - --- Resurgence of investor confidence through ARCH Venture Partners and Flagship Pioneering capital raises into the billions, and much more besides - Bristol Myers Squibb novel schizophrenia drug approval and what it might mean for nueroscience medicines in general You can view the entire episode here: https://lnkd.in/e-jVX2Av Much thanks to ed silverman and Boston Globe Media Benjamin McLeod BioPharm International Pharmaceutical Technology MJH Life Sciences®
-
Ahead of the headlines this time, with Nobel laureate predictions!
Behind the headlines Episode 3 here:https://lnkd.in/eQzBhgUs We discuss co-therapy research results from the June Lab presented at the Hanson Wade Group 9th CAR-TCR Summit; winter vaccine recommendations, particularly for respiratory syncytial virus (RSV) and Beyfortus access and deployment; upcoming early October Nobel prize announcement predictions; digital biology analytics, quantitation, alongside point of care (POC) and distributed manufacturing. We also talked about the Biosecure Act and manufacturing reshoring; Federal reserve interest rate cuts of a full half a percent (1); and the general investment and financial outlook. The Centers for Disease Control (CDC) recommends all babies be protected from severe RSV by one of two immunization options: A maternal RSV vaccine given to the mother during pregnancy, or an RSV antibody given to your baby. Most babies do not need both. The CDC now recommends an RSV vaccine for pregnant people to protect their babies from severe RSV disease. “Pregnant people should get a single dose of the maternal RSV vaccine (Pfizer’s Abrysvo) during weeks 32 through 36 of pregnancy. On our shortlist for the 2024 Nobel Prize in Physiology or Medicine, to be announced on Monday, October 7, 2024 at the earliest, were Pieter Cullis Tom Madden for lipid nanoparticles; Carl June Bruce Levine & Michel Sadeliene for CAR-T; Hans Clever and Donald Ingber, M.D., Ph.D. for Organoids; Sean Hart, PhD for laser force Cytology; and Steven Rosenberg for the development of tumor infiltrating lymphocyte therapy. #vaccine Beyfortus® (nirsevimab-alip) #Nobelprize #oncolgy #car-t Much thanks to Brian Feth xcellbio BioPharm International Pharmaceutical Technology
-
Sealed for Safety: A Deep Dive into Container Closure Integrity Wednesday, October 2, 2024 at 9am EST | 3pm CET https://lnkd.in/eDNDPvdJ
-
Navigating the Biologics CDMO Landscape We’d like to offer you exclusive access to an online resource with useful tools and practical information on navigating the biologics CDMO landscape. Access all resources: https://ow.ly/QUVa50ToC0F
-
New Ask the Expert! In this episode of the Ask the Expert video series, Peter Walters, Fellow of Advanced Therapies at CRB Group, discusses factors to be considered in constructing a new facility for cell and gene therapy production as well as using an existing facility to expand cell and gene therapy pipelines. https://lnkd.in/e_pvFpxi
Cell and Gene Therapy Production Facilities
pharmtech.com
-
EMA is recommending that the market authorization for Oxbryta (voxelotor) be suspended so that emerging data may be reviewed. https://lnkd.in/exfajV8h
EMA Suspends Sickle Cell Disease Medicine
pharmtech.com
-
New Ask the Expert! In this episode of the Ask the Expert video series, Peter Walters, Fellow of Advanced Therapies at CRB Group, discusses factors to be considered in constructing a new facility for cell and gene therapy production as well as using an existing facility to expand cell and gene therapy pipelines. https://lnkd.in/e_pvFpxi
Cell and Gene Therapy Production Facilities
pharmtech.com
-
We’d like to offer you exclusive access to an online resource with useful tools and practical information on Adare Pharma Solutions, a global technology-driven CDMO specializing in product development and commercial manufacturing. Access all resources: https://ow.ly/YvAb50ToCe4
-
BMS' news schizophrenia drug targets cholinergic receptors instead of the standard dopamine receptors. https://lnkd.in/evz7Pbcd
FDA Approves Schizophrenia Treatment that Targets Cholinergic Receptors
pharmtech.com